Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
34.68
-1.59 (-4.38%)
At close: Mar 5, 2026, 4:00 PM EST
35.36
+0.68 (1.96%)
After-hours: Mar 5, 2026, 6:02 PM EST

Veracyte Revenue

In the year 2025, Veracyte had annual revenue of $517.15M with 16.01% growth. Veracyte had revenue of $140.64M in the quarter ending December 31, 2025, with 18.55% growth.

Revenue (ttm)
$517.15M
Revenue Growth
+16.01%
P/S Ratio
5.33
Revenue / Employee
$627,603
Employees
824
Market Cap
2.76B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025517.15M71.38M16.01%
Dec 31, 2024445.76M84.71M23.46%
Dec 31, 2023361.05M64.52M21.76%
Dec 31, 2022296.54M77.02M35.09%
Dec 31, 2021219.51M102.03M86.85%
Dec 31, 2020117.48M-2.89M-2.40%
Dec 31, 2019120.37M28.36M30.82%
Dec 31, 201892.01M20.06M27.87%
Dec 31, 201771.95M6.87M10.55%
Dec 31, 201665.09M15.58M31.48%
Dec 31, 201549.50M11.31M29.62%
Dec 31, 201438.19M16.31M74.51%
Dec 31, 201321.88M10.26M88.20%
Dec 31, 201211.63M8.98M339.62%
Dec 31, 20112.65M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
ICON Public Limited Company8.10B
RadNet2.04B
Sotera Health Company1.16B
Neogen880.32M
NeoGenomics727.33M
GeneDx Holdings427.54M
Twist Bioscience391.56M
CareDx379.81M
Revenue Rankings